i3 Health
Oncology Data Advisor
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
Describing Real-World Treatment Patterns for Myelodysplastic Syndromes With Ira Zackon, MD 06.03.2023 13:03
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Studying Olutasidenib in Relapsed/Refractory Acute Myeloid Leukemia With Jorge Cortes, MD 06.03.2023 6:02
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Investigating Momelotinib for Treatment of Myelofibrosis With Srdan Verstovsek, MD, PhD 05.03.2023 5:49
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Additional Advances in Graft-Versus-Host Disease Research and Clinical Trials: Shernan Holtan, MD 04.03.2023 4:36
In 2022, Dr. Shernan Holtan, Associate Professor at the University of Minnesota Medical School, recorded a CME/NCPD activity centered on new therapeutic avenues for improved patient outcomes in graft-versus-host-disease (GVHD). Recently, at the American Society of Hematology (ASH) Annual Meeting, she presented results of the BMT CTN 1703 trial, which investigated the efficacy of a GVHD prophylaxis...
Additional Advances in NSCLC Research and Clinical Trials With Beth Sandy, MSN, CRNP 03.03.2023 15:52
Just under a year ago, Beth Sandy, a Thoracic Oncology Nurse Practitioner, co-led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity, Harnessing Immunotherapy-Based Strategies For Advanced Non–Small Cell Lung Cancer (NSCLC). In this interview, she provides an update on advancements made in treatment and supportive care strategies since recordi...
Additional Advances in Immune Thrombocytopenia Research and Clinical Trials 20.02.2023 9:52
In 2022, Allison Imahiyerobo, an Advanced Practice Nurse at the Englewood Health Physician Network in New Jersey, led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity with i3 Health, New Insights and Avenues for Improved Patient Outcomes in Immune Thrombocytopenia. A year later, Ms. Imahiyerobo sat down with Oncology Data Advisor to discuss...
Optimizing Patient Outcomes With CAR T-Cell Therapy With Ola Oluwole, MD 16.02.2023 4:52
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Improving the Standard of Care for Advanced Hodgkin Lymphoma With Mitul Gandhi, MD 16.02.2023 3:51
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Updates on Trials of Zilovertamab and Brentuximab Vedotin in Lymphomas With Hun Lee, MD 16.02.2023 8:26
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Investigating Brentuximab Vedotin for Advanced-Stage Hodgkin Lymphoma With Habte Yimer, MD 16.02.2023 4:48
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Subsequent Treatment After CAR T-Cell Therapy in Large B-Cell Lymphoma With Armin Ghobadi, MD 16.02.2023 5:55
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Creating Valuable Education for the Hematology/Oncology Fellow: Ronak Mistry and Vivek Patel 05.02.2023 8:00
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Factors Leading to Black Patient Disparities in Hematology Trials With Shakira Grant, MBBS 05.02.2023 5:21
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Making Health Care Accessible for Acute Myeloid Leukemia Patients With Ian Bouligny, MD 05.02.2023 7:34
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Advancing the Careers of Women in Hematology With Ariela Marshall, MD 05.02.2023 3:35
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Association of Socioeconomic Status With Adherence and Survival in Myeloma: Leon Bernal-Mizrachi, MD 05.02.2023 11:41
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Investigating CAR T Wait Time and High-Risk Myeloma Definitions With Samer Al Hadidi, MD, MS, FACP 02.02.2023 3:44
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Understanding Multiple Myeloma Treatment Patterns and Sequencing With Robert Rifkin, MD 02.02.2023 6:23
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Dynamic Risk Classification of Smoldering Myeloma With Luis Gerardo Rodríguez-Lobato, MD, PhD 02.02.2023 4:29
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Exploring the Results of Elranatamab for Relapsed/Refractory Multiple Myeloma With Noopur Raje, MD 02.02.2023 6:23
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Exploring Results of the SUNLIGHT Trial in Metastatic Colorectal Cancer: Josep Tabernero, MD, PhD 01.02.2023 7:42
At this weekend's American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancer Symposium, Dr. Josep Tabernero, Director of the Vall d'Hebron Institute of Oncology, presented results of the phase 3 SUNLIGHT trial of trifluridine/tipiracil plus bevacizumab for patients with metastatic colorectal cancer. In this interview, Dr. Tabernero further elaborates on the significance of this trea...
Investigating the Efficacy of HPN217 in Relapsed/Refractory Multiple Myeloma With Luke Walker, MD 27.01.2023 4:33
At the recent 64th American Society of Hematology (ASH) Annual Meeting in New Orleans, Dr. Luke Walker, Chief Medical Officer of Harpoon Therapeutics, sat down with Oncology Data Advisor to discuss the results of a phase 1 trial of HPN217, a B-cell maturation antigen (BCMA)–targeting T-cell engager, which were presented at the meeting. Dr. Walker delves into the efficacy that HPN217 demonstrated i...
Additional Advances in Chemotherapy-Induced Neutropenia Research and Clinical Trials 24.01.2023 10:14
In 2022, Dr. Maura Abbott, Associate Professor of Nursing at the Columbia University School of Nursing, served as faculty for i3 Health’s CME/NCPD approved activity, New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia. Now, in this follow-up interview with Oncology Data Advisor, Dr. Abbott reinforces the importance of educating patients who are at risk for chemotherapy-induc...
Studying the Promising Role of Bispecific Antibodies in Multiple Myeloma With Ajai Chari, MD 21.01.2023 8:20
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Discussing the Relevance of Urine Studies in Myeloma With Kelsey Natsuhara, MD 21.01.2023 4:58
This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!
Similar podcasts
Listen to the Oncology Data Advisor podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
